| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Gugino Matthew E | EVP & Chief Financial Officer | 2200 PENNSYLVANIA AVE NW, SUITE 800W, WASHINGTON | /s/ James F. O'Reilly, attorney-in-fact for Matthew E. Gugino | 02 Mar 2026 | 0002112904 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | DHR | Common Stock | 7,644 | 28 Feb 2026 | Direct | ||||||
| holding | DHR | Common Stock | 112 | 28 Feb 2026 | By 401(k) |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | DHR | Danaher Deferred Compensation Programs - Danaher Stock Fund | 28 Feb 2026 | Common Stock | 905 | Direct | F1, F2, F3 | |||||||
| holding | DHR | Employee stock option (right to buy) | 28 Feb 2026 | Common Stock | 4,210 | $76.47 | Direct | F4 | ||||||
| holding | DHR | Employee stock option (right to buy) | 28 Feb 2026 | Common Stock | 3,478 | $88.24 | Direct | F4 | ||||||
| holding | DHR | Employee stock option (right to buy) | 28 Feb 2026 | Common Stock | 3,309 | $100.81 | Direct | F4 | ||||||
| holding | DHR | Employee stock option (right to buy) | 28 Feb 2026 | Common Stock | 1,339 | $127.02 | Direct | F4 | ||||||
| holding | DHR | Employee stock option (right to buy) | 28 Feb 2026 | Common Stock | 3,343 | $139.30 | Direct | F4 | ||||||
| holding | DHR | Employee stock option (right to buy) | 28 Feb 2026 | Common Stock | 7,430 | $198.09 | Direct | F4 | ||||||
| holding | DHR | Employee stock option (right to buy) | 28 Feb 2026 | Common Stock | 2,420 | $198.09 | Direct | F4 | ||||||
| holding | DHR | Employee stock option (right to buy) | 28 Feb 2026 | Common Stock | 2,221 | $241.22 | Direct | F5 | ||||||
| holding | DHR | Employee stock option (right to buy) | 28 Feb 2026 | Common Stock | 5,079 | $240.13 | Direct | F6 | ||||||
| holding | DHR | Employee stock option (right to buy) | 28 Feb 2026 | Common Stock | 2,535 | $221.29 | Direct | F5 | ||||||
| holding | DHR | Employee stock option (right to buy) | 28 Feb 2026 | Common Stock | 1,931 | $255.87 | Direct | F5 | ||||||
| holding | DHR | Employee stock option (right to buy) | 28 Feb 2026 | Common Stock | 5,158 | $207.76 | Direct | F5 | ||||||
| holding | DHR | Employee stock option (right to buy) | 28 Feb 2026 | Common Stock | 10,410 | $221.21 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | Represents the participant's and/or Company contributions to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program. The reported securities reflect unfunded, notional shares of Danaher common stock calculated based on the closing price of Danaher common stock as reported on the NYSE on the date such compensation is credited. |
| F2 | The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission. |
| F3 | The notional shares convert on a one-for-one basis. |
| F4 | Date shown is grant date. Twenty percent of the options became or become exercisable on each of the first five anniversaries of the grant date. |
| F5 | Date shown is grant date. Twenty-five percent of the options became or become exercisable on each of the first four anniversaries of the grant date. |
| F6 | Date shown is grant date. Fifty percent of the options became or become exercisable on each of the third and fourth anniversaries of the grant date. |
Exhibit List: Exhibit 24 - Power of Attorney